J 2018

Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study

BRINKMAN, D. J., J. TICHELAAR, L. B. MOKKINK, T. CHRISTIAENS, R. LIKIC et. al.

Basic information

Original name

Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study

Authors

BRINKMAN, D. J., J. TICHELAAR, L. B. MOKKINK, T. CHRISTIAENS, R. LIKIC, R. MACIULAITIS, J. COSTA, E. J. SANZ, S. R. MAXWELL, M. C. RICHIR and M. A. VAN AGTMAEL

Edition

CLINICAL PHARMACOLOGY & THERAPEUTICS, HOBOKEN, WILEY, 2018, 0009-9236

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30104 Pharmacology and pharmacy

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 6.336

RIV identification code

RIV/00216224:14110/18:00121480

Organization unit

Faculty of Medicine

UT WoS

000440647100016

Keywords in English

Clinical Pharmacology; Therapeutics Education

Tags

International impact, Reviewed
Změněno: 28/4/2021 08:56, Mgr. Tereza Miškechová

Abstract

V originále

Harmonizing clinical pharmacology and therapeutics (CPT) education in Europe is necessary to ensure that the prescribing competency of future doctors is of a uniform high standard. As there are currently no uniform requirements, our aim was to achieve consensus on key learning outcomes for undergraduate CPT education in Europe. We used a modified Delphi method consisting of three questionnaire rounds and a panel meeting. A total of 129 experts from 27 European countries were asked to rate 307 learning outcomes. In all, 92 experts (71%) completed all three questionnaire rounds, and 33 experts (26%) attended the meeting. 232 learning outcomes from the original list, 15 newly suggested and 5 rephrased outcomes were included. These 252 learning outcomes should be included in undergraduate CPT curricula to ensure that European graduates are able to prescribe safely and effectively. We provide a blueprint of a European core curriculum describing when and how the learning outcomes might be acquired.

Links

90090, large research infrastructures
Name: CZECRIN II